ClinicalTrials.Veeva

Menu

Effects of Novel E-cigarette Constituents on Adults TCORS 3.0

Yale University logo

Yale University

Status

Enrolling

Conditions

Nicotine Use Disorder

Treatments

Other: E-liquid coolant (4% WS-23) for low (0.1%) menthol (6)
Other: E-liquid coolant (High [2.0%] WS-23) for low (0.1%) menthol (5)
Other: E-liquid coolant (Low [0.1%] WS-3) for high (2.0%) menthol (2)
Other: E-liquid coolant (Low [0.1%] WS-23) for low (0.1%) menthol (4)
Other: E-liquid coolant (High [2.0%] WS-23) for high (2.0%) menthol (5)
Other: E-liquid coolant (4% WS-23) for high (2.0%) menthol (6)
Other: E-liquid coolant (No WS-3) for low (0.1%) menthol (1)
Other: E-liquid coolant (Low [0.1%] WS-23) for non-menthol (4)
Other: E-liquid coolant (No WS-3) for non-menthol (1)
Other: E-liquid coolant (High [2.0%] WS-3) for low (0.1%) menthol (3)
Other: E-liquid coolant (No WS-3) for high (2.0%) menthol (1)
Other: E-liquid coolant (High [2.0%] WS-3) for non-menthol (3)
Other: E-liquid coolant (High [2.0%] WS-3) for high (2.0%) menthol (3)
Other: E-liquid coolant (4% WS-23) for non-menthol (6)
Other: E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2)
Other: E-liquid coolant (High [2.0%] WS-23) for non-menthol (5)
Other: E-liquid coolant (Low [0.1%] WS-23) for high (2.0%) menthol (4)
Other: E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05932745
2000035551_b
2U54DA036151-11 (Other Grant/Funding Number)

Details and patient eligibility

About

This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.

Full description

The investigators will examine the influence of cooling components of WS-3, WS-23 (synthetic coolants) and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults. Participants will rate the flavor intensity, coolness, sweetness, and irritation/harshness, bitterness experienced using validated rating scales. 66 adult participants (18+ years of age) who are current e-cigarette users will participate in 3 laboratory sessions. Participants will be randomized to receive one of the 3 menthol conditions (no-menthol, low menthol, high menthol) in Lab 1 and will receive the alternative conditions in randomized order in Lab 2 and Lab 3. During each lab session the menthol condition will be paired with three WS-3 concentrations: no WS-3, low (0.1%) WS-3, or high (2.0%) WS-3 and three WS-23 concentrations: low (0.1%) WS-23, high (2.0%) WS-23, or 4% WS-23 in randomized order. All e-cigarettes will contain nicotine salt at a nicotine concentration of ~59mg/ml and all participants will be exposed to eighteen conditions across 3 lab sessions.

Enrollment

66 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Able to read and write
  • Some current e-cigarette use
  • Urine cotinine ≥200ng/ml
  • Willing to abstain from tobacco/nicotine use 2 hours prior to sessions

Exclusion criteria

  • Current use of non-prescription substances besides nicotine, marijuana, alcohol
  • Any significant current medical or psychiatric condition
  • Known hypersensitivity to propylene glycol
  • Pregnant or lactating females
  • Uncontrolled asthma
  • Nut/e-liquid flavorant allergy
  • Current marijuana (tetrahydrocannabinol) vaping + E-cigarette or vaping use Associated Lung Injury (EVALI) symptoms
  • Dislike of menthol flavor

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

66 participants in 18 patient groups

Non-menthol, nicotine 59mg/ml (1)
Experimental group
Description:
Flavor without menthol with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (No WS-3) for non-menthol (1)
Low (0.1%) menthol, nicotine 59mg/ml (1)
Experimental group
Description:
Flavor with low menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (No WS-3) for low (0.1%) menthol (1)
High (2.0%) menthol, nicotine 59mg/ml (1)
Experimental group
Description:
Flavor with high menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (No WS-3) for high (2.0%) menthol (1)
Non-menthol, nicotine 59mg/ml (2)
Experimental group
Description:
Flavor without menthol with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2)
Low (0.1%) menthol, nicotine 59mg/ml (2)
Experimental group
Description:
Flavor with low menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2)
High (2.0%) menthol, nicotine 59mg/ml (2)
Experimental group
Description:
Flavor with high menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (Low [0.1%] WS-3) for high (2.0%) menthol (2)
Non-menthol, nicotine 59mg/ml (3)
Experimental group
Description:
Flavor without menthol with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (High [2.0%] WS-3) for non-menthol (3)
Low (0.1%) menthol, nicotine 59mg/ml (3)
Experimental group
Description:
Flavor with low menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (High [2.0%] WS-3) for low (0.1%) menthol (3)
High (2.0%) menthol, nicotine 59mg/ml (3)
Experimental group
Description:
Flavor with high menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (High [2.0%] WS-3) for high (2.0%) menthol (3)
Non-menthol, nicotine 59mg/ml (4)
Experimental group
Description:
Flavor without menthol with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (Low [0.1%] WS-23) for non-menthol (4)
Low (0.1%) menthol, nicotine 59mg/ml (4)
Experimental group
Description:
Flavor low menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (Low [0.1%] WS-23) for low (0.1%) menthol (4)
High (2.0%) menthol, nicotine 59mg/ml (4)
Experimental group
Description:
Flavor high menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (Low [0.1%] WS-23) for high (2.0%) menthol (4)
Non-menthol, nicotine 59mg/ml (5)
Experimental group
Description:
Flavor without menthol with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (High [2.0%] WS-23) for non-menthol (5)
Low (0.1%) menthol, nicotine 59mg/ml (5)
Experimental group
Description:
Flavor low menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (High [2.0%] WS-23) for low (0.1%) menthol (5)
High (2.0%) menthol, nicotine 59mg/ml (5)
Experimental group
Description:
Flavor high menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (High [2.0%] WS-23) for high (2.0%) menthol (5)
Non-menthol, nicotine 59mg/ml (6)
Experimental group
Description:
Flavor without menthol with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (4% WS-23) for non-menthol (6)
Low (0.1%) menthol, nicotine 59mg/ml (6)
Experimental group
Description:
Flavor low menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (4% WS-23) for low (0.1%) menthol (6)
High (2.0%) menthol, nicotine 59mg/ml (6)
Experimental group
Description:
Flavor high menthol concentration with 59mg/ml nicotine
Treatment:
Other: E-liquid coolant (4% WS-23) for high (2.0%) menthol (6)

Trial contacts and locations

1

Loading...

Central trial contact

Danielle Davis, PhD; Wei Li, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems